- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 13, 2025 | 85.37M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2025 | 85.07M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2025 | 84.94M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 82.46M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 82.27M sh |
| Operating Cash Flow | Q2 2025 · Mar 31, 2025 | −$17.98M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$18.97M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $115.77M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $132.19M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $99.76M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $110.92M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $120.26M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $134.96M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $135.58M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $141.85M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $17.38M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $15.3M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $117.14M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $135.57M |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | −$0.13 |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | −$0.27 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.13 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.23 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | −$0.13 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | −$0.27 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.13 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.23 |
| Rd Expense | Q2 2025 · Mar 31, 2025 | $9.89M |
| Rd Expense | Q2 2025 · Mar 31, 2025 | $20.34M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $9.73M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $18.41M |
| Net Income | Q2 2025 · Mar 31, 2025 | −$11.2M |
| Net Income | Q2 2025 · Mar 31, 2025 | −$23.31M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$10.55M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$19.17M |
| Operating Income | Q2 2025 · Mar 31, 2025 | −$12.51M |
| Operating Income | Q2 2025 · Mar 31, 2025 | −$26.11M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$12.62M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | −$24M |